Biomedicine Seminar
Title: The Clinical Genetics–Biomedicine Axis and Why It Makes Sense
Presenter: Uffe Birk Jensen, medical doctor & PhD
Info about event
Time
Location
Bldg. 1231-424 Lille Ana Aud
Abstract:
Almost every project in our group begins with a patient or a family. What follows is a search for the pathogenic variant using linkage analysis and WES/WGS. To understand the disease mechanism, we often need to introduce various models. This is where biomedicine becomes indispensable. This talk will trace that axis through five examples.
We start with a Danish family affected by an extremely rare disorder. Using linkage analysis and WES, we identified the FHL1 splice variant c.502-2A>T, which causes loss of FHL1A and FHL1B and roughly 200-fold overexpression of FHL1C. This results in an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. It is an example of how a change of one base pair out of 3 billion can produce two disorders. More than a decade later, how the C isoform produces the extended phenotype remains unresolved — a clinical observation still awaiting a mechanism.
In our diagnostic service, we often detect variants that may affect splicing. However, because the gene is unexpressed in accessible patient cells, we are unable to perform splice analysis. By adapting CRISPR activation into a diagnostic splicing assay, we have now been able to assess several splicogenic variants in different genes. We initially adopted this method using patient fibroblasts; however, to avoid a skin biopsy, we are currently testing whether we can activate the genes in EBV-transformed lymphocytes.
Third, in a family with X-linked complex spastic paraplegia, an interchromosomal insertion at Xq27.1 dysregulates SOX3through CTCF-dependent rewiring of the SOX3 TAD, as demonstrated in patient-derived iPSCs, isogenic CRISPR controls, Hi-C, and neural differentiation. This genetic altaration in this family was also discovered by using linkage analysis and WGS. During this project, we became interested in how TAD structure affects how CRISPR cuts DNA.
So in this fourth example, our CRISPR-TAD work showed that spatial proximity of double-strand breaks increases the frequency of large deletions and inversions in K562 cells. We are now dissecting the underlying DNA repair mechanisms to explain — and potentially modify — this proximity effect.
Finally, we are studying a phenotype new to our group: a large Danish pedigree with aortic dilation and a novel candidate gene. We used WES with segregation analysis to pinpoint the candidate locus and gene. By overexpressing the variant in zebrafish, we can recapitulate the human phenotype. However, the molecular mechanism remains unknown.